[An Exciting Opportunity]

As a global leader in the field of Structural Heart, the Boston Scientific Watchman team is transforming stroke prevention therapy for patients with atrial fibrillation. We are setting a new standard of care for non-valvular atrial fibrillation patients through innovative Left Atrial Appendage Closure (LAAC) therapy. And because its reimbursement is due in 2027, we focus on new customer development & education, and their in-service supports to ensure market readiness with the Watchman in the meantime. The Watchman device is a proven, safe, and effective alternative to long-term anticoagulant therapy, helping patients live safer and more independent lives. If you are passionate about making a meaningful difference in patients’ lives, this is your opportunity to join us. As a member of the Boston Scientific Watchman team, you will drive business growth and help fulfill our mission to advance patient health and quality of life.

[Purpose ...